Frontiers in Immunology | Cancer Immunity and Immunotherapy

Review

Published on 22 Jun 2023

Cutaneous immune-related adverse events to immune checkpoint inhibitors: from underlying immunological mechanisms to multi-omics prediction

in Cancer Immunity and Immunotherapy

Ting Cao
Xuyang Zhou
Xingbiao Wu
Ying Zou

Frontiers in Immunology

doi 10.3389/fimmu.2023.1207544

8,113 views
11 citations

Review

Published on 22 Jun 2023

New techniques: a roadmap for the development of HCC immunotherapy

in Cancer Immunity and Immunotherapy

Dizhi Jiang
Xinyue Ma
Xun Zhang
Bo Cheng
Ruiqing Wang
Yuan Liu
Xinyu Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1121162

8,328 views
15 citations

Review

Published on 22 Jun 2023

γδ T cells in immunotherapies for B-cell malignancies

in Cancer Immunity and Immunotherapy

Léa Rimailho
Carla Faria
Marcin Domagala
Camille Laurent
Christine Bezombes
Mary Poupot

Frontiers in Immunology

doi 10.3389/fimmu.2023.1200003

5,190 views
10 citations

Review

Published on 22 Jun 2023

Tumor-associated macrophages: new insights on their metabolic regulation and their influence in cancer immunotherapy

in Cancer Immunity and Immunotherapy

Li Xiao
Qiao Wang
Hongling Peng

Frontiers in Immunology

doi 10.3389/fimmu.2023.1157291

9,564 views
33 citations

Original Research

Published on 22 Jun 2023

A case report and literature review of immune checkpoint inhibitor-associated pneumonia caused by penpulimab

in Cancer Immunity and Immunotherapy

Rongmao Gao
Fuxun Yang
Chen Yang
Zhao Zhang
Mingzong Liu
Chunlin Xiang
Huan Hu
Xiaoxiu Luo
Jiajia Li
Rongan Liu

Frontiers in Immunology

doi 10.3389/fimmu.2023.1114994

4,556 views
5 citations

Original Research

Published on 22 Jun 2023

Expression of lymphoid structure-associated cytokine/chemokine gene transcripts in tumor and protein in serum are prognostic of melanoma patient outcomes

in Cancer Immunity and Immunotherapy

Lilit Karapetyan
Hassan M. AbuShukair
Aofei Li
Andrew Knight
Ayah Nedal Al Bzour
Ian P. MacFawn
Zachary J. Thompson
Ann Chen
Xi Yang
Rebekah Dadey

Frontiers in Immunology

doi 10.3389/fimmu.2023.1171978

6,556 views
10 citations

Review

Published on 22 Jun 2023

Targeted immune activation in pediatric solid tumors: opportunities to complement local control approaches

in Cancer Immunity and Immunotherapy

Emily P. Vonderhaar
Michael B. Dwinell
Brian T. Craig

Frontiers in Immunology

doi 10.3389/fimmu.2023.1202169

2,886 views
1 citation

Brief Research Report

Published on 21 Jun 2023

MK2 drives progression of pancreas and colon cancers by suppressing CD8+ T cell cytotoxic function and is a potential immunotherapy target

in Cancer Immunity and Immunotherapy

Damian Jacenik
Eric J. Lebish
Ellen J. Beswick

Frontiers in Immunology

doi 10.3389/fimmu.2023.1212100

3,614 views
3 citations

Mini Review

Published on 21 Jun 2023

Emerging role of deubiquitination modifications of programmed death-ligand 1 in cancer immunotherapy

in Cancer Immunity and Immunotherapy

Yao Jiang
Kai Hong
Yingchao Zhao
Kai Xu

Frontiers in Immunology

doi 10.3389/fimmu.2023.1228200

4,515 views
6 citations

Editorial

Published on 20 Jun 2023

Editorial: Ionizing radiation reprograms tumor immune microenvironment by inducing immunogenic cell death

in Cancer Immunity and Immunotherapy

Fei Yu
Kuangyu Shi
Shaoli Song
Haojun Chen
Weijun Wei

Frontiers in Immunology

doi 10.3389/fimmu.2023.1235024

2,738 views

Original Research

Published on 20 Jun 2023

Novel microRNAs modulating ecto-5′-nucleotidase expression

in Cancer Immunity and Immunotherapy

Theresa Kordaß
Tsu-Yang Chao
Wolfram Osen
Stefan B. Eichmüller

Frontiers in Immunology

doi 10.3389/fimmu.2023.1199374

3,906 views
4 citations

Editorial

Published on 20 Jun 2023

Editorial: Innovative 3D technologies in cancer immunity research and therapy

in Cancer Immunity and Immunotherapy

Deepak Gupta
Boris Chichkov
Zoltan Janos Vereb
Ibrahim T. Ozbolat

Frontiers in Immunology

doi 10.3389/fimmu.2023.1235483

2,235 views
1 citation

Review

Published on 19 Jun 2023

An updated review of gastrointestinal toxicity induced by PD-1 inhibitors: from mechanisms to management

in Cancer Immunity and Immunotherapy

Yiyu Cheng
Fangmei Ling
Junrong Li
Yidong Chen
Mingyang Xu
Shuang Li
Liangru Zhu

Frontiers in Immunology

doi 10.3389/fimmu.2023.1190850

7,558 views
15 citations

Original Research

Published on 19 Jun 2023

Transcriptome sequencing and single-cell sequencing analysis identify GARS1 as a potential prognostic and immunotherapeutic biomarker for multiple cancers, including bladder cancer

in Cancer Immunity and Immunotherapy

Jianqiang Nie
Taobin Liu
Taotao Mao
Hailang Yang
Wen Deng
Xiaoqiang Liu
Bin Fu

Frontiers in Immunology

doi 10.3389/fimmu.2023.1169588

5,712 views
6 citations

Original Research

Published on 19 Jun 2023

Breast cancer associated CD169+ macrophages possess broad immunosuppressive functions but enhance antibody secretion by activated B cells

in Cancer Immunity and Immunotherapy

Frida Björk Gunnarsdottir
Oscar Briem
Aida Yifter Lindgren
Eva Källberg
Cajsa Andersen
Robert Grenthe
Cassandra Rosenqvist
Camilla Rydberg Millrud
Mika Wallgren
Hannah Viklund

Frontiers in Immunology

doi 10.3389/fimmu.2023.1180209

6,939 views
18 citations

Systematic Review

Published on 19 Jun 2023

Severe and fatal adverse events of immune checkpoint inhibitor combination therapy in patients with metastatic renal cell carcinoma: a systematic review and meta-analysis

in Cancer Immunity and Immunotherapy

Yao-Ning Feng
Guang-Yu Xie
Li Xiao
Dun-Chang Mo
Jian-Feng Huang
Peng-Hui Luo
Xiu-Juan Liang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1196793

4,640 views
7 citations